Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

@article{Gautret2020HydroxychloroquineAA,
  title={Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial},
  author={P. Gautret and J. Lagier and P. Parola and V. T. Hoang and L. Meddeb and M. Mailhe and B. Doudier and J. Courjon and V. Giordanengo and Vera Esteves Vieira and H. Tissot Dupont and S. Honor{\'e} and P. Colson and E. Chabri{\`e}re and B. La Scola and J. Rolain and P. Brouqui and D. Raoult},
  journal={International Journal of Antimicrobial Agents},
  year={2020},
  volume={56},
  pages={105949 - 105949}
}
  • P. Gautret, J. Lagier, +15 authors D. Raoult
  • Published 2020
  • Biology, Medicine
  • International Journal of Antimicrobial Agents
  • Abstract Background Chloroquine and hydroxychloroquine have been found to be efficient on SARS-CoV-2, and reported to be efficient in Chinese COV-19 patients. We evaluate the role of hydroxychloroquine on respiratory viral loads. Patients and methods French Confirmed COVID-19 patients were included in a single arm protocol from early March to March 16th, to… CONTINUE READING

    Figures, Tables, and Topics from this paper.

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    CCAP is an investigator-initiated multicentre, randomized, double blinded, placebo-controlled, multi-stage trial, which aims to assess the safety and efficacy of novel treatment… Expand
    ConditionsCorona Virus Infection, COVID, Viral Pneumonia
    InterventionBiological, Drug, Other
    INTERVENTIONAL CLINICAL TRIAL
    This is an open label clinical study to evaluate the activity of chloroquine phosphate in patients with SARS-CoV-2 virus infection. The study aims to document possible prevention of… Expand
    ConditionsCovid-19, Pneumonia, Viral
    InterventionDrug
    INTERVENTIONAL CLINICAL TRIAL
    This is a Phase II pilot exploratory study designed to investigate if prophylactic treatment with short term steroids administered to high risk Covid-19 patient might prevent cytokine… Expand
    ConditionsCovid-19
    InterventionDrug
    OBSERVATIONAL CLINICAL TRIAL
    To compare various treatments provided to positive COVID-19 patients at locations across the OSF Ministry. Provide the opportunity to compare the effectiveness of various treatments and… Expand
    ConditionsCoronavirus, Coronavirus as the Cause of Diseases Classified Elsewhere, Coronavirus Disease, (+7 more)
    InterventionOther
    Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19
    • 258
    • PDF

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 35 REFERENCES
    Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
    • 1,954
    • PDF
    Chloroquine for the 2019 novel coronavirus SARS-CoV-2
    • 164
    • PDF
    Evaluation of Ebola Virus Inhibitors for Drug Repurposing.
    • 103